German Center for Diabetes Research
17
3
4
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 17 trials
100.0%
+13.5% vs industry average
18%
3 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
Intermittent Fasting to Improve Insulin Secretion
Role: collaborator
SGLT2 Inhibition in Addition to Lifestyle Intervention and Risk for Complications in Subtypes of Patients With Prediabetes
Role: collaborator
Breathing and Decision-Making
Role: collaborator
Combined Active Treatment in Type 2 Diabetes with NASH
Role: collaborator
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control (DIA-LINK Study)
Role: collaborator
Time-restricted Eating and Cognition
Role: collaborator
Improving Insulin Sensitivity by Non-invasive Brain Stimulation
Role: collaborator
Acute Effects of an Oral Fat Load on Skeletal Muscle and Hepatic Insulin Sensitivity
Role: collaborator
Towards a Better Understanding of Diabetes Distress, Depression and Poor Glycaemic Control in T2DM
Role: collaborator
POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 Diabetes
Role: collaborator
Diabetes Nutrition Algorithms - Sugars: Galactose- and Fiber-induced Metabolic Improvement in the Dietetic Treatment of Type 2 Diabetes
Role: collaborator
Diabetes Nutrition Algorithms in Patients With Overt Diabetes Mellitus
Role: collaborator
Improving Insulin Sensitivity by Non-invasive Brain Stimulation in Persons With Insulin Resistance
Role: collaborator
Depression and Diabetes Control Trial
Role: collaborator
Pre-POINT-Early Study
Role: collaborator
Neural Correlates of an Olive Oil Essence
Role: collaborator
How Fat Influences the Brain
Role: collaborator
All 17 trials loaded